Hamlet BioPharma was selected by Media Planet, the media agency for The Guardian, to be featured in the Health Awareness campaign, BLADDER AND BOWEL HEALTH,…
Read More
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Global Forum 2024 By BioStock,…
Med anledning bolagets delårsrapport för tredje kvartalet, bjuder Hamlet BioPharma in till en livesänd digital investerarträff fredagen den 24 maj klockan 12.00. Bolaget kommer att…
Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections – has successfully completed the first…
Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, has secured continued production of Alpha1-peptide…
Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces today that the commercial collaborations…
Immune responses in patients treated with Alpha1H – results published in the journal Cancer Medicine
Hamlet BioPharma announced on January 25 that clinical data showed a strong immune response with anti-tumor potential in Alpha1H-treated patients with bladder cancer. The submitted…
Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced technologies and the…
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s Life Science Investor Konference held in…